Nuveen Asset Management’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $546K | Sell |
8,889
-3,780
| -30% | -$232K | ﹤0.01% | 2955 |
|
|
2024
Q3 | $848K | Hold |
12,669
| – | – | ﹤0.01% | 2829 |
|
|
2024
Q2 | $846K | Buy |
12,669
+1,340
| +12% | +$89.5K | ﹤0.01% | 2797 |
|
|
2024
Q1 | $806K | Hold |
11,329
| – | – | ﹤0.01% | 2784 |
|
|
2023
Q4 | $954K | Buy |
11,329
+2,490
| +28% | +$210K | ﹤0.01% | 2751 |
|
|
2023
Q3 | $760K | Hold |
8,839
| – | – | ﹤0.01% | 2687 |
|
|
2023
Q2 | $824K | Hold |
8,839
| – | – | ﹤0.01% | 2728 |
|
|
2023
Q1 | $838K | Sell |
8,839
-125
| -1% | -$11.9K | ﹤0.01% | 2668 |
|
|
2022
Q4 | $901K | Sell |
8,964
-810
| -8% | -$81.4K | ﹤0.01% | 2722 |
|
|
2022
Q3 | $834K | Buy |
9,774
+98
| +1% | +$8.36K | ﹤0.01% | 2825 |
|
|
2022
Q2 | $831K | Sell |
9,676
-1,982
| -17% | -$170K | ﹤0.01% | 2872 |
|
|
2022
Q1 | $1.03M | Buy |
11,658
+125
| +1% | +$11K | ﹤0.01% | 2812 |
|
|
2021
Q4 | $1.25M | Sell |
11,533
-2,496
| -18% | -$269K | ﹤0.01% | 2775 |
|
|
2021
Q3 | $1.25M | Sell |
14,029
-1,620
| -10% | -$144K | ﹤0.01% | 2902 |
|
|
2021
Q2 | $1.33M | Buy |
15,649
+1,697
| +12% | +$144K | ﹤0.01% | 2893 |
|
|
2021
Q1 | $1.21M | Sell |
13,952
-806
| -5% | -$69.8K | ﹤0.01% | 2830 |
|
|
2020
Q4 | $1.24M | Buy |
14,758
+977
| +7% | +$82.4K | ﹤0.01% | 2727 |
|
|
2020
Q3 | $1.1M | Buy |
13,781
+574
| +4% | +$45.9K | ﹤0.01% | 2643 |
|
|
2020
Q2 | $1.17M | Sell |
13,207
-283
| -2% | -$25.1K | ﹤0.01% | 2562 |
|
|
2020
Q1 | $1.27M | Buy |
13,490
+6,752
| +100% | +$635K | ﹤0.01% | 2406 |
|
|
2019
Q4 | $727K | Sell |
6,738
-6,180
| -48% | -$667K | ﹤0.01% | 2800 |
|
|
2019
Q3 | $1.24M | Sell |
12,918
-756
| -6% | -$72.5K | ﹤0.01% | 2606 |
|
|
2019
Q2 | $1.31M | Buy |
+13,674
| New | +$1.31M | ﹤0.01% | 2626 |
|